Wright M Jerry, Vann Robert E, Gamage Thomas F, Damaj M Imad, Wiley Jenny L
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298-0613 USA.
Pharmacol Biochem Behav. 2006 Nov;85(3):507-13. doi: 10.1016/j.pbb.2006.09.020. Epub 2006 Nov 16.
While the role of dextrorphan and dextromethorphan as N-methyl-d-aspartate (NMDA) receptor antagonists has received considerable research attention, their effects on nicotinic acetylcholine receptors (nAChR) has been less well characterized. Recent in vitro and in vivo research has suggested that these drugs noncompetitively block alpha3beta4*, alpha4beta2, and alpha7 nAChR subtypes and antagonize nicotine's antinociceptive and reinforcing effects. Both drugs were most potent at blocking alpha3beta4* AChR. This study investigated the effects of dextrorphan and dextromethorphan on nicotine's discriminative stimulus effects. Three groups of rats were trained in a two-lever drug discrimination procedure to discriminate 0.4 mg/kg s.c. nicotine from saline. Nicotine dose-dependently substituted for itself in all three groups. In contrast, when dextrorphan (group 1) or dextromethorphan (group 2) were injected i.p., neither substitution for nor antagonism of nicotine was observed for either drug. Since i.p. administration allows substantial metabolism of dextromethorphan to its parent compound dextrorphan, the two drugs were also tested following s.c. administration (group 3). Discrimination results were similar across both routes of administration, in that neither substitution nor antagonism occurred, however, s.c. administration reduced response rates to a much greater extent than did i.p. administration. Previous work suggests that beta2 subunits are crucial for mediation of nicotine's discriminative stimulus effects and may play a role in its reinforcing effects, albeit other research suggests a role for alpha3beta4* nicotinic receptors in the latter. Our results suggest that alpha3beta4* nicotinic receptors do not play a major role in nicotine's discriminative stimulus effects. Further, they suggest that the role of cholinergic mediation of the behavioral effects of dextrorphan and dextromethorphan related to the abuse properties of nicotine may be minimal.
虽然右啡烷和右美沙芬作为N-甲基-D-天冬氨酸(NMDA)受体拮抗剂的作用已受到相当多的研究关注,但其对烟碱型乙酰胆碱受体(nAChR)的影响却鲜为人知。最近的体外和体内研究表明,这些药物可非竞争性地阻断α3β4*、α4β2和α7 nAChR亚型,并拮抗尼古丁的镇痛和强化作用。两种药物对α3β4* AChR的阻断作用最强。本研究调查了右啡烷和右美沙芬对尼古丁辨别刺激效应的影响。三组大鼠在双杠杆药物辨别程序中接受训练,以区分皮下注射0.4mg/kg尼古丁和生理盐水。在所有三组中,尼古丁均呈剂量依赖性地替代自身。相比之下,当腹腔注射右啡烷(第1组)或右美沙芬(第2组)时,两种药物均未观察到对尼古丁的替代或拮抗作用。由于腹腔注射会使右美沙芬大量代谢为其母体化合物右啡烷,因此还对皮下注射这两种药物进行了测试(第3组)。两种给药途径的辨别结果相似,即既未发生替代也未出现拮抗作用,然而,皮下注射比腹腔注射对反应率的降低程度更大。先前的研究表明,β2亚基对于介导尼古丁的辨别刺激效应至关重要,并且可能在其强化效应中发挥作用,尽管其他研究表明α3β4烟碱受体在后者中起作用。我们的结果表明,α3β4烟碱受体在尼古丁的辨别刺激效应中不发挥主要作用。此外,它们表明,右啡烷和右美沙芬与尼古丁滥用特性相关的行为效应的胆碱能介导作用可能很小。